Gilead Sciences Inc (NASDAQ:GILD) | U.S. lawmakers ask Gilead about Sovaldi pricing

[Reuters] – U.S. lawmakers have asked for a briefing from Gilead Sciences Inc on the price of new hepatitis C drug Sovaldi. A letter to Gilead from Democrats in the House Energy & . . . → Read More: Gilead Sciences Inc (NASDAQ:GILD) | U.S. lawmakers ask Gilead about Sovaldi pricing Similar Articles: Gilead Sciences Inc. (NASDAQ:GILD) – Should You Sell Gilead Sciences After A Successful 2013? Gilead Sciences Inc. (NASDAQ:GILD) ~ January 2014 Options Now Available For Gilead Sciences (GILD) Gilead Sciences Inc. (NASDAQ:GILD) – New Hepatitis C Drug Success Should Drive Gilead Sciences In 2014